NORGES BANK - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$270,000
-84.6%
11,600
-87.4%
0.00%
Q3 2021$1,753,000
+34.8%
92,200
+42.9%
0.00%
Q2 2021$1,300,000
+162.1%
64,500
+158.0%
0.00%
Q3 2019$496,000
+137.3%
25,000
+39.1%
0.00%
Q4 2014$209,000
-84.1%
17,968
-84.1%
0.00%
-100.0%
Q3 2014$1,316,000112,9680.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders